YOYael Oestreicher‐Kedem

Yael Oestreicher‐Kedem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yael Oestreicher‐Kedem has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Ari DeRowe

    Pediatric Otolaryngology Unit, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    1 shared publication
  • Britta Hardy

    Department of Cellular Immunology, Felsenstein Medical Research Center, Beilinson Campus, Petah Tiqva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1 shared publication
  • Eyal Raveh

    Departments of Otolaryngoloy, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1 shared publication
  • Galia Grissaru

    Infectious Disease Unit, Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    1 shared publication
  • Hannah Tamary

    Hematology/Oncology, Schneider Childern's Medical Center of Israel, Petah Tiqva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1 shared publication
  • Isaac Yaniv

    Hematology/Oncology, Schneider Childern's Medical Center of Israel, Petah Tiqva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    1 shared publication

Latest Publications

  • Arterial brain infarction in complicated acute otitis media

    by Yael Oestreicher-Kedem, Liat Ben-Sira, Galia Grissaru, Ari DeRowe


  • Diagnostic value of galectin‐3 as a marker for malignancy in follicular patterned thyroid lesions

    by Yael Oestreicher‐Kedem, Marisa Halpern, Pepi Roizman, Britta Hardy, Jaqueline Sulkes, Raphael Feinmesser, Yoram Stern

    Background.: The determination of malignancy in follicular patterned thyroid lesions is based on postoperative histologic findings. Therefore, affected patients are referred for surgery, although only 20% will have a final diagnosis of malignancy. The aim of this study was to investigate the potential of galectin‐3 as a marker of malignancy in these lesions.Methods.: Fifty‐four tissue specimens of follicular patterned thyroid lesions were immunohistochemically stained for galectin‐3. Area and intensity scores were recorded.Results.: Significant differences were found between the benign and malignant lesions. The sensitivity, specificity, positive predictive values, and negative predictive values of galectin‐3 staining were 82%, 68%, 75%, and 77%, respectively (p = .0002). Significant differences were also found between the subgroups of benign and malignant lesions (p ≤ .05).Conclusions.: Galectin‐3 staining is highly sensitive for malignancy in follicular patterned thyroid lesions. Diagnostic problems may arise in the presence of Hürthle cell proliferation or minimally invasive follicular carcinoma. © 2004 Wiley Periodicals, Inc. Head Neck 26: 960–966, 2004


  • Prothrombotic Factors in Children with Otitis Media and Sinus Thrombosis

    by Yael Oestreicher‐Kedem, Eyal Raveh, Liora Kornreich, Isaac Yaniv, Hannah Tamary

    Objective Venous sinus thrombosis (VST) is the second most common intracranial complication of acute otitis media (AOM). There is some evidence that hereditary and acquired prothrombotic disorders are risk factors for VST. The aim of the present study was to evaluate whether children with AOM complicated VST have a prothrombotic tendency, which might have important therapeutic and preventive implications.Study Design Retrospective.Methods The files of children hospitalized at Schneider Children's Medical Center of Israel, a tertiary referral center, from 1999 to 2002, because of AOM complicated by acute mastoiditis and VST were reviewed. All children underwent laboratory work‐up for hypercoagulability.Results Seven children met the study criteria. Of these, five had prothrombotic disorders, namely elevated levels of lipoprotein apolipoprotein (Lp[a]) (n = 4), antibodies to beta 2‐glycoprotein and to cardiolipin (markers of antiphospholipid syndrome) (n = 4), and heterozygosity for factor V Leiden mutation (n = 1). One child had three abnormalities, two children had two abnormalities, and two children had one abnormality.Conclusions A prothrombotic tendency may exist in children with AOM complicated by mastoiditis and VST. Further studies are needed to evaluate its extent.